World News: 12:30 GMT Tuesday 28th May 2019. [Translate Bio, Inc. via Globe Newswire via SPi World News]
LEXINGTON, Mass., May 28, 2019 (GLOBE NEWSWIRE) -- Translate Bio, Inc. (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, today announced that Ronald Renaud, chief executive officer, will present a corporate overview at the Jefferies 2019 Healthcare Conference in New Yok, NY, on Tuesday, June 4, 2019, at 10:30 a.m. ET.
A live webcast of the session will be accessible through the “Events and Presentations” page of the Company's website at investors.translate.bio. A replay of the webcast will be archived on Translate Bio’s website for 30 days following the presentation.
Globe Newswire: 12:30 GMT Tuesday 28th May 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.